Abstract B69: VAL401 decreases tumor volume in a xenograft model of pancreatic cancer utilizing a novel improved luciferase labelling technique

MLA

George Morris, et al. “Abstract B69: VAL401 Decreases Tumor Volume in a Xenograft Model of Pancreatic Cancer Utilizing a Novel Improved Luciferase Labelling Technique.” Molecular Cancer Therapeutics, vol. 14, Dec. 2015, p. B69. EBSCOhost, https://doi.org/10.1158/1535-7163.targ-15-b69.

APA

George Morris, Jenni Bernoulli, Jussi M. Halleen, Johanna Tuomela, Mari I. Suominen, Suzanne J. Dilly, Matthias Bozza, Richard Harbottle, & Katja M. Fagerlund. (2015). Abstract B69: VAL401 decreases tumor volume in a xenograft model of pancreatic cancer utilizing a novel improved luciferase labelling technique. Molecular Cancer Therapeutics, 14, B69. https://doi.org/10.1158/1535-7163.targ-15-b69

Chicago

George Morris, Jenni Bernoulli, Jussi M. Halleen, Johanna Tuomela, Mari I. Suominen, Suzanne J. Dilly, Matthias Bozza, Richard Harbottle, and Katja M. Fagerlund. 2015. “Abstract B69: VAL401 Decreases Tumor Volume in a Xenograft Model of Pancreatic Cancer Utilizing a Novel Improved Luciferase Labelling Technique.” Molecular Cancer Therapeutics 14 (December): B69. doi:10.1158/1535-7163.targ-15-b69.